You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 62 No. 7, July 2005 TABLE OF CONTENTS
  Archives
  •  Online Features
  Editorial
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (5)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Cognitive Disorders
 •Nutritional and Metabolic Disorders
 •Nutritional and Metabolic Disorders, Other
 •Alert me on articles by topic

Insulin Resistance and Cognitive Impairment

A View Through the Prism of Epidemiology

Arch Neurol. 2005;62:1043-1044.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

The relationship between insulin resistance and neurodegenerative disease is tantalizing in its potential to offer an integrated architecture for aging of the body and the brain. While there are contradictory findings in this area, the prevalence of insulin resistance is reportedly increased in many age-related neurodegenerative disorders, including Alzheimer disease, vascular dementia, and Parkinson disease.1 Insulin resistance may contribute to the expression of these disorders through shared as well as distinct mechanisms. Identification of these mechanisms could aid the development of effective preventative and therapeutic strategies.

In this issue, Geroldi et al2 report an ambitious study that views the relationship between insulin resistance and cognitive impairment through the prism of epidemiology. While this approach can identify important trends in large populations, it requires careful delineation of criteria to define a sample and its subgroups. Each criterion may refract the investigators’ perspective, which may in turn modify the likelihood of obtaining . . . [Full Text of this Article]

AUTHOR INFORMATION

Suzanne Craft, PhD


RELATED ARTICLE

Insulin Resistance in Cognitive Impairment: The InCHIANTI Study
Cristina Geroldi, Giovanni B. Frisoni, Giuseppe Paolisso, Stefania Bandinelli, Marco Lamponi, Angela Marie Abbatecola, Orazio Zanetti, Jack M. Guralnik, and Luigi Ferrucci
Arch Neurol. 2005;62(7):1067-1072.
ABSTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Glucose Homeostasis in Huntington Disease: Abnormalities in Insulin Sensitivity and Early-Phase Insulin Secretion
Lalic et al.
Arch Neurol 2008;65:476-480.
ABSTRACT | FULL TEXT  

Advances in Vascular Cognitive Impairment 2006
Bowler and Gorelick
Stroke 2007;38:241-244.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2005 American Medical Association. All Rights Reserved.